Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
argenx SE - American Depositary Shares
(NQ:
ARGX
)
616.17
+1.41 (+0.23%)
Streaming Delayed Price
Updated: 11:57 AM EDT, Apr 28, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about argenx SE - American Depositary Shares
< Previous
1
2
3
4
5
6
7
8
9
Next >
Does ARGENX SE - ADR (NASDAQ:ARGX) meet the Minervini criteria?
April 26, 2025
A fundamental and technical analysis of (NASDAQ:ARGX): Is ARGENX SE - ADR (NASDAQ:ARGX) suited for high growth investing?
Via
Chartmill
$100 Invested In This Stock 5 Years Ago Would Be Worth This Much Today
April 21, 2025
Via
Benzinga
What's Driving the Market Sentiment Around argenx?
April 21, 2025
Via
Benzinga
Here's How Much You Would Have Made Owning argenx Stock In The Last 5 Years
April 18, 2025
Via
Benzinga
FDA Approves Argenx's Vyvgart Hytrulo Prefilled Syringe For Self-Injection For At Home Use Setting
April 11, 2025
FDA approves Argenx's Vyvgart Hytrulo prefilled syringe for self-injection in gMG and CIDP, offering flexible dosing and expanding treatment options.
Via
Benzinga
Exposures
Product Safety
Argenx Bounds Off 200-Day Line On 'Best-Case Scenario' For Blockbuster Drug
April 11, 2025
The prefilled syringe will cost 4% more than the under-the-skin shot.
Via
Investor's Business Daily
Exposures
Product Safety
P/E Ratio Insights for argenx
March 20, 2025
Via
Benzinga
What Analysts Are Saying About argenx Stock
March 04, 2025
Via
Benzinga
What 11 Analyst Ratings Have To Say About argenx
April 11, 2025
Via
Benzinga
Why Argenx Shares Are Trading Higher By 5%; Here Are 20 Stocks Moving Premarket
April 11, 2025
Via
Benzinga
Pharma Industry Faces Jitters As Trump Hints At Historic Tariffs, BofA Outlines Probable Timeline
April 09, 2025
Trump hints at major tariffs on foreign pharmaceuticals, sparking concerns for Indian suppliers and potential hikes in U.S. drug costs.
Via
Benzinga
Topics
Government
Supply Chain
World Trade
Exposures
Political
Supply Chain
Tariff
If You Invested $100 In This Stock 5 Years Ago, You Would Have This Much Today
March 04, 2025
Via
Benzinga
Earnings Scheduled For February 27, 2025
February 27, 2025
Via
Benzinga
$1000 Invested In This Stock 5 Years Ago Would Be Worth This Much Today
February 19, 2025
Via
Benzinga
Here's How Much You Would Have Made Owning argenx Stock In The Last 5 Years
January 30, 2025
Via
Benzinga
Argenx's Flagship Drug Vyvgart Shows Sustained Disease Control In Rare Neuromuscular Disease Patients
April 08, 2025
Argenx reports long-term Vyvgart data showing lasting efficacy in gMG and CIDP, with strong safety and symptom control across multiple studies.
Via
Benzinga
Here's How Much You Would Have Made Owning argenx Stock In The Last 5 Years
March 31, 2025
Via
Benzinga
Looking Into argenx's Recent Short Interest
March 26, 2025
Via
Benzinga
Biohaven Slumps, Again, As Bipolar Setback Outweighs A $4 Billion Opportunity
March 04, 2025
Analysts remains bullish on the company's chances in depression and epilepsy. But investors aren't convinced.
Via
Investor's Business Daily
Here's How Much You Would Have Made Owning argenx Stock In The Last 5 Years
January 16, 2025
Via
Benzinga
Biotech Stocks Prepare For Action In 2025. Weight-Loss Drugs, AI And Trump 2.0 Are The Catalysts.
January 09, 2025
Biotech stocks have seen three years of sideways to down trading. But obesity drugs, AI and Trump 2.0 promise to shake things up.
Via
Investor's Business Daily
Topics
Artificial Intelligence
Government
Exposures
Artificial Intelligence
Political
Here's How Much You Would Have Made Owning argenx Stock In The Last 5 Years
January 03, 2025
Via
Benzinga
$1000 Invested In argenx 5 Years Ago Would Be Worth This Much Today
December 18, 2024
Via
Benzinga
Biohaven Advances in Immunotherapy: Significant IgG Reduction Achieved with BHV-1300, Gains Analyst Approval
December 17, 2024
Biohaven's BHV-1300 shows >60% IgG reduction in early trials with promising safety data, advancing its MoDE platform and regulatory milestones.
Via
Benzinga
Looking Into argenx's Recent Short Interest
December 09, 2024
Via
Benzinga
(ARGX) - Analyzing argenx's Short Interest
November 14, 2024
Via
Benzinga
This Bristol-Myers Squibb Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
November 12, 2024
Via
Benzinga
Peering Into argenx's Recent Short Interest
November 06, 2024
Via
Benzinga
This eBay Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
November 05, 2024
Via
Benzinga
Argenx Q3 Revenue, EPS Beats Excite Bullish Biotech Analysts: 'Most Enviable I&I Pipeline In Entire Industry'
November 01, 2024
Argenx SE ADR shares jumped after impressive earnings. Analysts raised price targets and noted strong pipeline and global expansion.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.